OIS Retina Speakers 2022

Thomas M. Aaberg, Jr., MD, PhD

Thomas M. Aaberg, Jr., MD, PhD

Retina Specialists of Michigan / CMO - Neurotech

Caroline R. Baumal, MD

Caroline R. Baumal, MD

New England Eye Center, Tufts Medical Center

Robert B. Bhisitkul, MD, PhD

Robert B. Bhisitkul, MD, PhD

University of California San Francisco School of Medicine

Pierre Billardon

Pierre Billardon

DORC International B.V.

David Boyer, MD Retina Vitreous Associates Medical Group

David Boyer, MD

David Boyer, MD

Retina Vitreous Associates Medical Group

Paul Bresge

Paul Bresge

Ray Therapeutics

Greg Butz

Greg Butz

Bank of America Merrill Lynch

Thomas Ciulla, MD, MBA

Thomas Ciulla, MD, MBA

Clearside Biomedical / Indiana University School of Medicine / Midwest Eye Institute

Eugene de Juan, MD

Eugene de Juan, MD

UCSF Department of Ophthalmology

Pravin U. Dugel, MD

Pravin U. Dugel, MD

Iveric Bio

David A. Eichenbaum, MD

David A. Eichenbaum, MD

Retina Vitreous Associates of Florida

David Esposito

David Esposito

ONL Therapeutics

Claire Gelfman, PhD

Claire Gelfman, PhD

Foundation Fighting Blindness

Shamika Gune, MD

Shamika Gune, MD

Genentech

Paul Hallen

Paul Hallen

Alcon

Erin Henry, PhD

Erin Henry, PhD

NGM Biopharmaceuticals

Nancy Holekamp, MD

Nancy Holekamp, MD

Pepose Vision Institute

J. Jill Hopkins, MD

J. Jill Hopkins, MD

Novartis

Jean-Pierre Hubschman, MD

Jean-Pierre Hubschman, MD

Stein Eye Institute at UCLA

Mark-Humayun

Mark Humayun, MD, PhD

Mark Humayun, MD, PhD

University of Southern California Roski Eye Institute

PAV

Peter Kaiser, MD

Peter Kaiser, MD

Cole Eye Institute

Jerry Lee, MBA

Jerry Lee, MBA

Goldman Sachs

James C. Murray

James C. Murray

ExSight Ventures

Aaron Nagiel, MD, PhD

Aaron Nagiel, MD, PhD

Keck School of Medicine of USC

John S. Pollack, MD

John S. Pollack, MD

Illinois Retina Associates / CMO - jCyte, Inc

Firas M. Rahhal, MD

Firas M. Rahhal, MD

ExSight Ventures & Retina Vitreous Associates Medical Group

Robert Rothman

Robert Rothman, MD

Robert Rothman, MD

InFocus Capital Partners /Glaucoma Consultants of Long Island

Russell Trenary

Russell Trenary

Outlook Therapeutics

Glenn C. Yiu, MD, PhD

Glenn C. Yiu, MD, PhD

UC Davis Health Department of Ophthalmology & Vision Science